PATENT CLAIM ANALYSIS

Application Number: 16351620
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "236800"]

Abstract:
The invention provides a method of inhibiting a TYK2 kinase, which method comprises bringing into contact with the TYK2 kinase an effective TYK2 kinase-inhibiting amount of a compound having the formula (0): or a salt or stereoisomer thereof. The invention also provides a novel subset of compounds within formula (0) as well as pharmaceutical compositions containing them and their use in medicine.

Claim (Index 23):
A pharmaceutical composition comprising a compound as defined in claim  1  and a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14529902', '12599653', '11265516', '14598973', '12297491']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.73705138353689
- 35 USC 102 Novelty (BERT): 0.47180631439222
- Combined Prediction Score: 0.7105268766224231
- Mean Citation Score: 178.247334
- Max Citation Score: 193.26096
- Similarity Product: 160.59560144288062

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test